跳至主要内容
临床试验/CTRI/2023/06/054120
CTRI/2023/06/054120尚未招募3 期

Controlled Clinical Study To Evaluate Efficacy of Amrita Guggulu & Dhatri Nisha Vati In Prameha w.s.r Type-2 Diabetes Mellitus.

Dr Andleev Aaftab0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Newly diagnosed patient ( <2yrs) of Prameha w.r.t
  • type-2 Diabetes Mellitus.
  • 2) Subjects of age group b/w 30-70 yrs (30-70 both
  • inclusive) will be in the inclusive.
  • 3) Both male and female (female- non lactating and
  • not pregnant) will be in the inclusion.
  • 4) HbA1c >6.5 ( <60mmol/mol) within previous 3
  • 5) Diabetes Mellitus with F.B.S. > 126-mg%,
  • 6) Post Prandial Blood Sugar >200mg%.
  • 7) Written consent showing willingness to participate
  • in the study.
  • 8) Patient will be taken according to American
  • Medical Association Criteria for diagnosis of
  • Diabetes Mellitus.

排除标准

  • 1) Subjects with Type-1 Diabetes will be in the exclusion.
  • 2) Pregnant women, Lactating women will be in the exclusion.
  • 3) Subjects with creatinine >1.5 will be in the exclusion
  • 4) Fasting blood sugar >300mg% will be in exclusion.
  • 5) Post Prandial Blood Sugar >400mg%.
  • 6) HbA1c >9.0%( >75mmol/mol) will be in the exclusion criteria.
  • 7) Subjects with known cases of Diabetic complications like diabetic
  • nephropathy, retinopathy, cardiovascular disease will be in the exclusion.
  • 8) Subjects with history of stroke, myocardial infarction, in the last 6 months
  • will be in the exclusion.
  • 9) Subjects of known cases of active infective diseases like Tuberculosis,
  • HIV, Hept-B will be in the exclusion

研究者

发起方
Dr Andleev Aaftab

相似试验